Login to Your Account

Pharma: Other News To Note

Tuesday, February 28, 2012
• Roche AG, of Basel, Switzerland, said it extended its cash offer to acquire all outstanding shares of Illumina Inc., of San Diego, at a price of $44.50 per share, to 6 p.m. ET March 23. The tender offer previously was set to expire at midnight ET Feb. 24. All other terms of the proposed $5.7 billion bid for the tools firm remain the same.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription